This Week’s Big ETF Stories

It was a banner week for U.S. stocks as the S&P 500 and the Nasdaq Composite raced to record highs. With its 2.7% gain for the week, the Nasdaq Composite returned to levels not seen since the height of the dot-com bubble.

Adding to the risk-on feeling permeating markets, West Texas Intermediate futures, the benchmark U.S. crude oil contract, climbed 2.5% for the week, good for the sixth consecutive weekly gain. With that good cheer heading into the weekend, let’s get into some of this week’s most important ETF stories.

Broad Market/Sector ETFs

Investors are forcing fund fees lower and that’s a good thing. [Investors are Getting a Good Deal With ETFs]

Missing out on the latest Nasdaq party.

Equal-weight the Nasdaq way is working just fine. [This Equal-Weight ETF is Working Just Fine]

Plenty of fun for this pharma ETF.

Analyst says biotech run has more gas in the tank. [Biotech ETF Party not Over Yet]

Dividend ETFs wait on another payout hike from Apple.

Business is booming for smart beta ETFs. [Business is Booming for These ETFs]